Fewer than 1 in 3 children with hepatitis C (HCV) see a clinician for care, and fewer than 1 in 8 receive treatment.

A mother gives her baby immunity even before birth. Vaccines during pregnancy protect both, boosting the baby's defense ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Through funding from Student Council, students are now able to receive free STI testing with SHW which includes tests for HIV ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...

US biotech Atossa Therapeutics (Nasdaq: ATOS) has entered into a research collaboration with China-backed Nona Biosciences, aiming to identify next-generation antibody therapies for breast cancer ...

Credit: RealPeopleGroup via Getty Images. UK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that collates work from the two companies’ alternative antibody isotopes for ...

Over 300 cases of hepatitis A have been reported so far ... has resulted in a growing number of people without protective antibodies who are highly susceptible to infection. This mainly concerns ...

That’s what happens in Antiphospholipid Antibody Syndrome (APS). It’s a health issue most people haven’t heard of, but it can lead to serious problems like blood clots, strokes, and ...